NM_001349.4:c.1277T>C
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM2PP2PP3PP5
The NM_001349.4(DARS1):c.1277T>C(p.Leu426Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000997 in 1,103,272 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001349.4 missense
Scores
Clinical Significance
Conservation
Publications
- hypomyelination with brain stem and spinal cord involvement and leg spasticityInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DARS1 | NM_001349.4 | c.1277T>C | p.Leu426Ser | missense_variant | Exon 14 of 16 | ENST00000264161.9 | NP_001340.2 | |
DARS1 | NM_001293312.1 | c.977T>C | p.Leu326Ser | missense_variant | Exon 13 of 15 | NP_001280241.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 250510 AF XY: 0.00000738 show subpopulations
GnomAD4 exome AF: 0.0000105 AC: 10AN: 950988Hom.: 0 Cov.: 16 AF XY: 0.0000101 AC XY: 5AN XY: 494332 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74476 show subpopulations
ClinVar
Submissions by phenotype
Hypomyelination with brain stem and spinal cord involvement and leg spasticity Pathogenic:1
A heterozygous missense variant, NM_001349.2(DARS):c.1277T>C, has been identified in exon 14 of 16 of the DARS gene. This substitution creates a major amino acid change of a leucine to serine at position 426, NP_001340.2(DARS):p.(Leu426Ser). The leucine residue at this position has very high conservation (100 vertebrates, UCSC). It is located within an aminoacyl tRNA synthetase class II domain. In-silico predictions for this variant are consistently pathogenic (Polyphen, SIFT, CADD, Mutation Taster). The variant is present in the gnomAD database at a frequency of 0.0001 (0 homozygotes). The variant has been previously described in a homozygous state as pathogenic in a patient with leukoencephalopathy (Wolf, N. et al., (2015)). Based on the information available at the time of curation, this variant has been classified as LIKELY PATHOGENIC. -
not provided Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 426 of the DARS protein (p.Leu426Ser). This variant is present in population databases (rs377510027, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of leukodystrophy (PMID: 25527264). ClinVar contains an entry for this variant (Variation ID: 488394). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at